Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Fish and Richardson
Fuji
Harvard Business School
Mallinckrodt
Colorcon
Johnson and Johnson
Citi

Generated: July 16, 2018

DrugPatentWatch Database Preview

Fospropofol disodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for fospropofol disodium and what is the scope of fospropofol disodium freedom to operate?

Fospropofol disodium
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fospropofol disodium has thirty-four patent family members in twenty-five countries.

Summary for fospropofol disodium
Synonyms for fospropofol disodium
258516-87-9
30868AY0IF
AC-25763
AC1MI4YF
ACN-049983
AKOS024406472
AN-3709
Aquavan
Aquavan (TN)
Aquavan injection
CHEMBL2021422
D02EZM
D04257
dipotassium 2,6-diisopropylphenoxymethyl phosphate
disodium (2,6-diisopropylphenoxy)methyl phosphate
disodium [2,6-di(propan-2-yl)phenoxy]methyl phosphate
DISODIUM 2,6-DIISOPROPYLPHENOXYMETHYL PHOSPHATE
DTXSID10180504
FOSPROPOFOL DISODIUM (AQUAVAN)
Fospropofol disodium (USAN)
Fospropofol disodium salt
GPI 15715
GPI-15715
KB-52180
LS-192060
Lusedra
Lusedra (TN)
Methanol, (2,6-bis(1-methylethyl)phenoxy)-, dihydrogen phosphate, disodium salt
OR068284
OR249427
phosphoric acid 2,6-diisopropylphenoxymethyl monoester disodium salt
PQ-1002
UNII-30868AY0IF

US Patents and Regulatory Information for fospropofol disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc LUSEDRA fospropofol disodium SOLUTION;INTRAVENOUS 022244-001 Dec 12, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Eisai Inc LUSEDRA fospropofol disodium SOLUTION;INTRAVENOUS 022244-001 Dec 12, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for fospropofol disodium

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,451,776 Water soluble prodrugs of hindered alcohols ➤ Try a Free Trial
7,244,718 Water soluble prodrugs of hindered alcohols ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Mallinckrodt
Moodys
Queensland Health
US Department of Justice
Teva
Dow
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.